SCHEMBL2915766

SCHEMBL2915766

O=[N+]([O-])c1cc2c(c(OCBr)c1)CCC(NCCO)CC2

nearest known ligand 0.43

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
GRIN2B Q13224 4/20 0.43
TSHR P16473 1/20 0.37
TDP1 Q9NUW8 1/20 0.37
CXCR4 P61073 1/20 0.35
NPBWR1 P48145 1/20 0.33
MCHR1 Q99705 1/20 0.33
DRD2 P14416 4/20 0.32
DRD3 P35462 2/20 0.32
DRD4 P21917 1/20 0.32
OPRK1 P41145 1/20 0.31
POLB P06746 1/20 0.31
CYP19A1 P11511 2/20 0.30
L3MBTL1 Q9Y468 1/20 0.30
HDAC8 Q9BY41 1/20 0.30
LMNA P02545 1/20 0.30
HPGD P15428 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2915322 0.87 GRIN2B (0.41) GRIN2BCXCR4NPBWR1MCHR1DRD2
SCHEMBL2915405 0.84 GRIN2B (0.39) GRIN2BCXCR4NPBWR1MCHR1DRD2
SCHEMBL2482262 0.76 CYP19A1 (0.33) TSHRTDP1CYP19A1
SCHEMBL2482409 0.73 KMT2A (0.37) POLBLMNA
SCHEMBL2916318 0.71 DRD2 (0.31) DRD2
SCHEMBL2061002 0.67 MAPT (0.36) GRIN2BCXCR4DRD2DRD3OPRK1
SCHEMBL10035936 0.61 MAPT (0.55) POLB
SCHEMBL8182158 0.60 SPHK1 (0.36) GRIN2BCXCR4OPRK1
SCHEMBL6052431 0.59 ALDH1A1 (0.60) TDP1L3MBTL1LMNA
SCHEMBL2061291 0.59 DRD2 (0.41) GRIN2BDRD2DRD3DRD4POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2222647-A1 FUSED BICYCLIC DERIVATIVES OF 2,4-DIAMINOPYRIMIDINE AS ALK AND C-MET INHIBITORS Cephalon, Inc. (US) 2010-09-01 EP disclosed
WO-2008051547-A1 FUSED BICYCLIC DERIVATIVES OF 2,4-DIAMINOPYRIMIDINE AS ALK AND C-MET INHIBITORS CEPHALON, INC. (US) 2008-05-02 WO disclosed